CRYOPDP—centered around clinical trials, biopharma, and cell and gene therapies—augments DHL’s specialty pharma logistics ...

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Colin Banas, MD, DrFirst’s chief ...

A roundtable explores how patient access needs are being measured, while also discussing the value of affordability in ...

Titled “State of the Industry—The Evolving Landscape of Healthcare Coverage and Access in 2025,” 1 the goal of the Access USA ...

Jen Butler, chief commercial officer, Pleio, discusses the importance of balancing technology and personalization in patient ...

Renier Brentjens, MD, PhD outlines the evolution of the space, while offering ways to boost patient access to these ...

Jen Butler, chief commercial officer, Pleio, discusses how personalization, connectivity, technology, and proactive support ...

The move by the CDMO—who also houses a North American HQ in Indiana—expresses its interest in providing compliant storage and ...

Jonathan James, CEO, Hope Charities, discusses the challenge of nonprofits securing sustainable funding while ensuring ...

Jonathan James, CEO, Hope Charities, discusses reimbursement challenges and barriers to care in patients requiring ...

Jen Butler, chief commercial officer, Pleio, discusses how the company’s GoodStart programs help patients navigate specialty ...

1. AstraZeneca to invest $2.5 billion in new global strategic R&D centre, biotech agreements and manufacturing in Beijing.